JA
ELV icon

John Armitage’s Elevance Health ELV Stock Holding History

John Armitage’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-694,185
Closed -$199M – 33
2019
Q1 		$199M Buy
694,185
+443,428
+177% +$128M 1.41% 23
2018
Q4 		$65.9M Buy
+250,757
New +$69M 0.55% 25

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

John Armitage's ELV Position: Q2 2019 in Review

John Armitage sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 694,185 shares — an estimated $199M sold.

John Armitage first reported a position in ELV in Q4 2018 and held it in 2 quarters. The position peaked at $199M in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

  • John Armitage reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
  • John Armitage sold 694,185 Elevance Health shares in Q2 2019, an estimated $199M.
  • John Armitage first reported a position in Elevance Health in Q4 2018 and held it in 2 quarters.
  • John Armitage's Elevance Health position peaked at $199M in Q1 2019.
  • 1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Egerton Capital (UK)'s 13F filing for Q2 2019, filed 13 Aug 2019.